SCHEDULE 13G
SCHEDULE 13GSchedule 13G ownership disclosure
Assembly Biosciences Inc
Common Stock, par value $0.001 per shares (the "Shares") · CUSIP: 045396207
Event date: 2025-08-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Farallon Capital Partners, L.P.
Shares: 222,174 · Class: 1.4%
- Farallon Capital Institutional Partners, L.P.
Shares: 208,105 · Class: 1.3%
- Farallon Capital Institutional Partners II, L.P.
Shares: 69,803 · Class: 0.4%
- Farallon Capital Institutional Partners III, L.P.
Shares: 45,211 · Class: 0.3%
- Four Crossings Institutional Partners V, L.P.
Shares: 54,002 · Class: 0.3%
- Farallon Capital Offshore Investors II, L.P.
Shares: 462,782 · Class: 3%
- Farallon Capital (AM) Investors, L.P.
Shares: 30,637 · Class: 0.2%
- Farallon Capital F5 Master I, L.P.
Shares: 47,796 · Class: 0.3%
- Farallon Partners, L.L.C.
Shares: 1,092,714 · Class: 7%
- Farallon Institutional (GP) V, L.L.C.
Shares: 54,002 · Class: 0.3%
- Farallon F5 (GP), L.L.C.
Shares: 47,796 · Class: 0.3%
- Dapice Joshua J.
Shares: 1,140,510 · Class: 7.3%
- Dreyfuss, Philip D.
Shares: 1,140,510 · Class: 7.3%
- Dunn Hannah E.
Shares: 1,140,510 · Class: 7.3%
- Fried, Richard B
Shares: 1,140,510 · Class: 7.3%
- Gehani, Varun N.
Shares: 1,140,510 · Class: 7.3%
- Giauque, Nicolas
Shares: 1,140,510 · Class: 7.3%
- Kim, David T.
Shares: 1,140,510 · Class: 7.3%
- Linn, Michael G.
Shares: 1,140,510 · Class: 7.3%
- Luo Patrick (Cheng)
Shares: 1,140,510 · Class: 7.3%
- Patel, Rajiv A.
Shares: 1,140,510 · Class: 7.3%
- Roberts, Jr., Thomas G.
Shares: 1,140,510 · Class: 7.3%
- Saito Edric C.
Shares: 1,140,510 · Class: 7.3%
- Seybold, William
Shares: 1,140,510 · Class: 7.3%
- Short Daniel S.
Shares: 1,140,510 · Class: 7.3%
- Spokes, Andrew J. M.
Shares: 1,140,510 · Class: 7.3%
- Warren, John R.
Shares: 1,140,510 · Class: 7.3%
- Wehrly, Mark C.
Shares: 1,140,510 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000908834-25-000255
- Form type
- SCHEDULE 13G
- Filer
- ASSEMBLY BIOSCIENCES, INC.
- CIK
- CIK 1426800
- Filed
- Aug 15, 2025
- Reporting period
- Aug 08, 2025
- Description
- Schedule 13G beneficial ownership